5 de enero de 2023 • 1 minute read
Science and the law: Prepare for 2023 with our 10 most popular life sciences insights
Throughout 2022, DLA Piper’s lawyers have continued providing you with insights on the latest business and legal developments at the intersection of science and the law. Here are 10 of our most popular podcasts and publications that we think will help guide you into 2023.
The life sciences supply chain today can seem especially fragile. Listen to our At the Intersection of Science and Law podcast.
While biological events may be inevitable, their level of impact on our country is not, says former BIO CEO Jim Greenwood.
As you seek to protect the IP you are developing around CRISPR technologies, here are some issues to keep in mind.
How are medical device and pharmaceutical companies protecting their AI innovations in the face of new regulations and risks? Listen to our podcast.
Regulatory incentives could drive better racial and ethnic diversity. Listen to our podcast.
When do products, facilities, labels, and claims require Formal Premarket Approval, and when do they not?
The proposed EU AI Regulation will impact every company in the life sciences supply chain.
The decision provides useful guidance regarding public statements about products in development.
The enormous progress of biopharmaceutical innovation is being undermined because too many patients can’t afford these drugs. Modest reforms could be the fix. Listen to our podcast.
FDA adopts a more aggressive enforcement strategy for delta-8 THC and moves against products that carry significant risk of youth appeal.
